US › Healthcare

Cumberland Pharmaceuticals Inc (CPIX)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$7.19+3.01%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$166,458

Revenue YoY

-98.5%

Net profit

$-4.1M

EPS

$-0.20

Net margin

-2,472.5%

Key statistics

Market cap

$104.6M

Forward P/E

50.0

P/B

5.71

Book value

$1.16

EPS (TTM)

$-0.23

52-week high

$9.28

52-week low

$1.13

50-day MA

$7.23

200-day MA

$4.97

Beta

0.10

Analyst view

Analysts rate Cumberland Pharmaceuticals Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $8.50.

Shareholding

Insiders

41.60%

Institutions

16.53%

Largest institutional holders

Fund	Stake
Ikarian Capital, LLC	3.69%
Renaissance Technologies Corp	3.14%
Vanguard Capital Management, LLC	2.41%
Dimensional Fund Advisors, Inc.	1.56%
Perceptive Advisors LLC	1.31%
Bridgeway Capital Management, LLC	1.09%
BOOTHBAY FUND MANAGEMENT, LLC	0.85%
Geode Capital Management, LLC	0.76%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Cumberland Pharmaceuticals Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.